Metformin as an Upstream Therapy in Atrial Fibrillation
Status:
Terminated
Trial end date:
2018-07-10
Target enrollment:
Participant gender:
Summary
The purpose of this study is to see if the study drug metformin will help patients who are
overweight and have atrial fibrillation. This study aims to see if metformin helps patients
stay in normal sinus rhythm after a catheter ablation.
Metformin is investigational for use in patients with atrial fibrillation. Metformin is
approved by the Food and Drug Administration (FDA) for use in patients with type 2 Diabetes
Mellitus. Metformin is used with a proper diet and exercise program to control high blood
sugar, and has been shown to help people lose weight. This study aims to look at the effects
of metformin on weight loss and heart rhythm in patients with atrial fibrillation.